PD-1 blockade boost vaccine-induced anti-HIV responses in the absence of HIV reactivation

• J.G. Prado,
• M. Marin Lopez,
• E. Jimenez-Moyano,
• D. Ouchi,
• O. Blanch-Lombarte,
• D. Gorman,
• T. Hanke,
• C. Brander,
• B. Howell,
• B. Mothe

Affiliations

J.G. Prado

IrisiCaixa, Badalona, Spain

M. Marin Lopez

IrisiCaixa, Badalona, Spain

E. Jimenez-Moyano

IrisiCaixa, Badalona, Spain

D. Ouchi

IrisiCaixa, Badalona, Spain

O. Blanch-Lombarte

IrisiCaixa, Badalona, Spain

D. Gorman

Merck & Co. Inc., Palo Alto, California, USA

T. Hanke

Jenner Institute Nuffield Department of Medicine, University of Oxford, Oxford, UK

C. Brander

IrisiCaixa, Badalona, Spain

B. Howell

Department of Infectious Disease, Merck & Co. Inc., Kenilworth, NJ, USA

B. Mothe

IrisiCaixa, Badalona, Spain